User profiles for Yukihiko Shirayama

Yukihiko Shirayama

Teikyo University Chiba Medical Center
Verified email at rapid.ocn.ne.jp
Cited by 9851

Brain-derived neurotrophic factor produces antidepressant effects in behavioral models of depression

Y Shirayama, ACH Chen, S Nakagawa… - Journal of …, 2002 - Soc Neuroscience
Previous studies demonstrated that antidepressant treatment increases the expression of
brain-derived neurotrophic factor (BDNF) in rat hippocampus. The present study was …

Expression of the cAMP response element binding protein (CREB) in hippocampus produces an antidepressant effect

ACH Chen, Y Shirayama, KH Shin, RL Neve… - Biological …, 2001 - Elsevier
Background: Recent studies have demonstrated that chronic antidepressant treatment
increases the expression of the cyclic amp (cAMP) response element binding protein (CREB) in …

Correlation between plasma levels of glutamate, alanine and serine with severity of depression

H Mitani, Y Shirayama, T Yamada, K Maeda… - Progress in neuro …, 2006 - Elsevier
The goal of this study was to evaluate the utility of using plasma levels of amino acids as an
indicator of the severity of depression. The samples were collected from 23 depressed …

Stress increases dynorphin immunoreactivity in limbic brain regions and dynorphin antagonism produces antidepressant‐like effects

Y Shirayama, H Ishida, M Iwata… - Journal of …, 2004 - Wiley Online Library
Rats exposed to learned helplessness (LH), an animal model of depression, showed a
recovery following an intracerebroventricular injection of nor‐binaltorphimine dihydrochloride (…

Antidepressant effects of TrkB ligands on depression-like behavior and dendritic changes in mice after inflammation

…, Q Ren, C Yang, S Li, Y Shirayama… - International Journal …, 2015 - academic.oup.com
Background: Brain-derived neurotrophic factor (BDNF) and its receptor, tropomyosin-related
kinase B (TrkB), signaling represent potential therapeutic targets for major depressive …

[HTML][HTML] Negative Correlation between Brain Glutathione Level and Negative Symptoms in Schizophrenia: A 3T 1H-MRS Study

D Matsuzawa, T Obata, Y Shirayama, H Nonaka… - PloS one, 2008 - journals.plos.org
Background Glutathione (GSH), a major intracellular antioxidant, plays a role in NMDA
receptor-mediated neurotransmission, which is involved in the pathophysiology of schizophrenia. …

Neurochemistry of the nucleus accumbens and its relevance to depression and antidepressant action in rodents

Y Shirayama, S Chaki - Current neuropharmacology, 2006 - ingentaconnect.com
There is accumulating evidence that the nucleus accumbens (NAc) plays an important role in
the pathophysiology of depression. Given that clinical depression is marked by anhedonia (…

[HTML][HTML] Beta-hydroxybutyrate, an endogenic NLRP3 inflammasome inhibitor, attenuates stress-induced behavioral and inflammatory responses

…, T Iitsuka, T Yamauchi, A Miura, S Pu, Y Shirayama… - Scientific reports, 2017 - nature.com
Neuro-inflammation has been shown to play a critical role in the development of depression.
Beta-hydroxybutyrate (BHB) is a ketone body and has recently been reported to exert anti-…

High occupancy of sigma-1 receptors in the human brain after single oral administration of fluvoxamine: a positron emission tomography study using [11C] SA4503

…, R Miyatake, M Fujisaki, E Shimizu, Y Shirayama… - Biological …, 2007 - Elsevier
BACKGROUND: Sigma-1 receptors might be implicated in the pathophysiology of psychiatric
diseases, as well as in the mechanisms of action of some selective serotonin reuptake …

Alterations in brain-derived neurotrophic factor (BDNF) and its precursor proBDNF in the brain regions of a learned helplessness rat model and the antidepressant …

Y Shirayama, C Yang, J Zhang, Q Ren, W Yao… - European …, 2015 - Elsevier
Shirayama and Hashimoto designed the study and wrote the protocol. Drs. … Shirayama and
Yang undertook the statistical analysis. Drs. Shirayama and Hashimoto wrote the first draft of …